InsiderSource
AGIO

AGIOS PHARMACEUTICALS, INC.

SEC CIK 1439222
$33.08 +22.8% · 90 days
90-day buys
$0
0 open-market
90-day sells
$1.2M
7 open-market
Net insider flow
−$1.2M
Net selling
Filings shown
140
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at AGIO have sold a net $1.2M of stock (0 open-market buys vs 7 sells).

Largest recent trade: Burns James William sold $697.4K of AGIO, trimming their stake 36%.

Most active filer: Gheuens Sarah, with 27 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for AGIO, newest first
View on SEC EDGAR ↗
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Scadden David · Director · Open-market sale · filed Oct 10, 2025 ΔOwn −1.1%

Scadden David sold $8.2K of AGIO, trimming their stake 1%.

−$8.2K
200 sh @ $41
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Jones Cecilia · Chief Financial Officer · Open-market sale · filed Sep 30, 2025 ΔOwn −9.7%

Jones Cecilia sold $134.2K of AGIO, trimming their stake 10%.

−$134.2K
3,651 sh @ $37
Advertisement
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Aug 12, 2025 ΔOwn −8.2%

Goff Brian sold $406.5K of AGIO, trimming their stake 8%.

−$406.5K
11,085 sh @ $37
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Scadden David · Director · Open-market sale · filed Jul 15, 2025 ΔOwn −7.4%

Scadden David sold $56K of AGIO, trimming their stake 7%.

−$56K
1,400 sh @ $40
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −15%

Gheuens Sarah sold $419.8K of AGIO, trimming their stake 15%.

−$419.8K
11,067 sh @ $38
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 11, 2025 ΔOwn −1.4%

Gheuens Sarah sold $32.8K of AGIO, trimming their stake 1%.

−$32.8K
847 sh @ $39
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jul 3, 2025 ΔOwn −6.3%

Gheuens Sarah sold $139.8K of AGIO, trimming their stake 6%.

−$139.8K
4,091 sh @ $34
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Jun 26, 2025 ΔOwn −4.9%

Gheuens Sarah sold $97.6K of AGIO, trimming their stake 5%.

−$97.6K
2,909 sh @ $34
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Jones Cecilia · Chief Financial Officer · Open-market sale · filed Jun 26, 2025 ΔOwn −5.6%

Jones Cecilia sold $59.7K of AGIO, trimming their stake 6%.

−$59.7K
1,780 sh @ $34
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Milanova Tsveta · Chief Commercial Officer · Open-market sale · filed Jun 26, 2025 ΔOwn −9.6%

Milanova Tsveta sold $92.9K of AGIO, trimming their stake 10%.

−$92.9K
2,770 sh @ $34
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Jun 26, 2025 ΔOwn −11%

Goff Brian sold $418.3K of AGIO, trimming their stake 11%.

−$418.3K
12,471 sh @ $34
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Jun 26, 2025 ΔOwn −5.3%

Goff Brian sold $208.9K of AGIO, trimming their stake 5%.

−$208.9K
6,229 sh @ $34
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Jones Cecilia · Chief Financial Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −2.6%

Jones Cecilia sold $21.1K of AGIO, trimming their stake 3%.

−$21.1K
594 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Jones Cecilia · Chief Financial Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −6.1%

Jones Cecilia sold $59.7K of AGIO, trimming their stake 6%.

−$59.7K
1,681 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Milanova Tsveta · Chief Commercial Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −6.8%

Milanova Tsveta sold $59.7K of AGIO, trimming their stake 7%.

−$59.7K
1,681 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −4.8%

Goff Brian sold $147.6K of AGIO, trimming their stake 5%.

−$147.6K
4,153 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Goff Brian · Director, Chief Executive Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −8.7%

Goff Brian sold $312.5K of AGIO, trimming their stake 9%.

−$312.5K
8,794 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −2.4%

Gheuens Sarah sold $40.4K of AGIO, trimming their stake 2%.

−$40.4K
1,137 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −2.3%

Gheuens Sarah sold $42.2K of AGIO, trimming their stake 2%.

−$42.2K
1,187 sh @ $36
AGIO
AGIOS PHARMACEUTICALS, INC.
Sell Gheuens Sarah · Chief Medical Officer · Open-market sale · filed Mar 4, 2025 ΔOwn −3.0%

Gheuens Sarah sold $59.7K of AGIO, trimming their stake 3%.

−$59.7K
1,681 sh @ $36
Advertisement

About AGIO insider activity

This page tracks every recent Form 4 filed for AGIOS PHARMACEUTICALS, INC. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is AGIO insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for AGIOS PHARMACEUTICALS, INC. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.